Ronald Saff, MD
Allergy & Immunology · Tallahassee, FLNPI 1528075249
Payments from drug & device makers
Across 823 payments — averaging $1502.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$299K
- AstraZeneca$270K
- Teva Pharmaceuticals USA, Inc.$218K
- GSK$162K
- Chiesi USA, Inc.$121K
- Amphastar Pharmaceuticals, Inc.$105K
- plus $62K from 27 others
Across 2 payments — averaging $521.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$1K
- Genentech, Inc.$31
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 59 | $298,755 |
| AstraZeneca | 103 | $270,455 |
| Teva Pharmaceuticals USA, Inc. | 89 | $217,679 |
| GSK | 151 | $162,235 |
| Chiesi USA, Inc. | 47 | $120,949 |
| Amphastar Pharmaceuticals, Inc. | 3 | $104,636 |
| Regeneron | 119 | $32,177 |
| Astrazeneca UK Limited | 2 | $16,500 |
| Eli Lilly | 1 | $4,250 |
| Acerta Pharma LLC | 1 | $3,456 |
| Regeneron Healthcare Solutions, Inc. | 56 | $1,308 |
| Sanofi | 35 | $809 |
| Boehringer Ingelheim | 36 | $647 |
| Alk-abello, Inc | 37 | $585 |
| Genentech USA, Inc. | 16 | $439 |
| Pharming Healthcare, Inc. | 9 | $322 |
| Amgen | 12 | $252 |
| Grifols USA, LLC | 10 | $193 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $106 |
| Blueprint Medicines Corporation | 4 | $97 |
| Incyte Corporation | 3 | $95 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Aimmune Therapeutics, Inc. | 4 | $83 |
| Biocryst US Sales Co., LLC | 3 | $69 |
| Optinose US, Inc. | 3 | $51 |
| Ionis Pharmaceuticals, Inc. | 1 | $50 |
| Pfizer | 3 | $49 |
| Lilly USA, LLC | 2 | $46 |
| LEO Pharma Inc. | 2 | $38 |
| Merck | 2 | $38 |
| Hikma Pharmaceuticals USA | 2 | $32 |
| Kaleo, Inc. | 2 | $29 |
| Dermavant Sciences, Inc. | 1 | $14 |
How this compares
$1,236,528 in reported general payments places this provider in the 95th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Tallahassee
- Jaime LandmanAventura$3.9M
- Ileana RodicioMiami$3.8M
- Jose CarpioMiami$3.6M
- Michael KohenDaytona Beach$3.6M
- Thomas CasaleTampa$1.7M
- Dennis LedfordTampa$1.4M
- Shahnaz FattehPlantation$1M
- Seong ChoTampa$969K
- Thomas WestbrookPensacola$925K
- Nina RamirezMiami$833K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.